Lilly (Eli) (LLY) is a pharmaceuticals company in the Health Care sector. Listed on the NASDAQ, Lilly (Eli) is a component of the S&P 500 index. As of 2026-06-10, the stock is trading at $1136.37.
Key Metrics & Risk
Based on 5-year historical data from Yahoo Finance (daily returns, annualized using 252 trading days).
| Metric | Value |
|---|---|
| Latest Price | $1136.37 |
| Latest Date | 2026-06-10 |
| Expected Return (Annualized) | 38.83% |
| Risk / Std Dev (Annualized) | 32.45% |
| Sharpe Ratio (rf=4.5%) | 1.06 |
S&P 500 Context
- Sector: Health Care
- Sub-Industry: Pharmaceuticals
- Exchange: NASDAQ
- Index: S&P 500 Component
Risk/Return Profile
The stock shows an annualized expected return of 38.83% with an annualized volatility of 32.45%. The Sharpe ratio of 1.06 (assuming 4.5% risk-free rate) indicates attractive risk-adjusted returns relative to the risk-free rate.
Modern Portfolio Theory Positioning
This stock is plotted on the S&P 500 Modern Portfolio Theory chart which visualizes the risk/return trade-off across all S&P 500 components. The chart uses Sharpe ratio as the color dimension, allowing quick identification of stocks with superior risk-adjusted performance.
Fundamentals
| Metric | Value |
|---|---|
| Market Cap | 1013.35B |
| Enterprise Value | 1051.44B |
| Trailing P/E | 40.33 |
| Forward P/E | 25.54 |
| Price to Book | 32.54 |
| Price to Sales | 14.03 |
| EV/Revenue | 14.55 |
| EV/EBITDA | 29.03 |
| Profitability | | | Profit Margin | 34.99% | | Operating Margin | 49.39% | | ROE | 107.46% | | ROA | 20.74% |
| Growth | | | Revenue Growth | 55.5% | | Earnings Growth | 169.9% |
| Dividend | | | Dividend Yield | 61.0% | | Payout Ratio | 22.13% | | 5Y Avg Yield | 89.0% |
| Financial Health | | | Total Revenue | 72.25B | | Total Debt | 43.37B | | Total Cash | 5.28B | | Free Cash Flow | 9.16B | | Operating Cash Flow | 20.48B |
| Price & Technical | | | 52W High | $1182.73$ | | 52W Low | $623.78$ | | 50-Day Avg | $983.39$ | | 200-Day Avg | $952.01$ | | Beta | 0.52 | | Shares Outstanding | 0.89B | | Float Shares | 0.89B | | Insider Holdings | 0.15% | | Institutional Holdings | 85.33% | | Short Ratio | 2.75 | | Short % of Float | 1.1% |
| Analyst Targets | | | Target High | $1500.0$ | | Target Low | $850.0$ | | Target Mean | $1215.79$ | | Target Median | $1251.0$ | | # of Analysts | 29 | | Recommendation | buy |
Disclaimer
This analysis is for educational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Always conduct your own research or consult a qualified financial advisor before making investment decisions.